Jason P Rhodes $DYN SEC Form 4 Insider Trading

Jason P Rhodes has filed a total of 36 insider trades in $DYN since 2021. Their most recent trade was a sale of 123 shares, made on Nov 14, 2024. Their largest trade was a purchase of 934,581 shares, made on Dec 12, 2022. We estimate that they now own 2.0 million shares of $DYN, worth an estimated $21.3 million.

Insider Trading at $DYN

There have been a total of 331 insider trades reported at $DYN since 2021, with 3.6 million shares purchased and 8.5 million shares sold. The most active insider traders in $DYN stock have been Oxana Beskrovnaya, Susanna Gatti High, and Richard William Scalzo. The most recent trade was a sale of 143 shares reported by Johanna Friedl-Naderer (Chief Commercial Officer), made on Mar 13, 2025.

$DYN Executives and Stock Owners with Insider Trades

• Oxana Beskrovnaya, Chief Scientific Officer

• Susanna Gatti High, Chief Operating Officer

• Richard William Scalzo, SVP, Head of Finance & Admin.

• Jonathan Mcneill, Chief Business Officer

• Wildon Farwell, Chief Medical Officer

• Joshua T Brumm, CEO & President

• Joshua T Brumm, See Remarks

• Richard William Scalzo, See Remarks

• Jonathan Mcneill, See Remarks

• John Cox, CEO & President

• Douglas Kerr, Chief Medical Officer

• Johanna Friedl-Naderer, Chief Commercial Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.